News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current TRSSF market cap is 603.31M. The company's latest EPS is USD -0.2724 and P/E is -8.33.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 90.35M | 147.83M | 210.42M | 250.51M | 317.33M |
| Operating Income | -134.94M | 20.5M | 31.93M | -349.7M | -14.21M |
| Net Income | -215.79M | -139.2M | 3.11M | -329.91M | -95.55M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 460.77M | 427.24M | 581.93M | 701.59M | 666.52M |
| Total Liabilities | 385.44M | 440.56M | 352.98M | 380.42M | 425.78M |
| Total Equity | 75.33M | -13.32M | 228.95M | 321.17M | 240.74M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -47.91M | -36.97M | -31.82M | -26.12M | 27.47M |
| Investing | -138.22M | -45.89M | -132.42M | -27.58M | -16.22M |
| Financing | 176.98M | 133.41M | 182.2M | 3.72M | -12.5M |
| Market Cap | 603.31M |
| Price to Earnings Ratio | -8.33 |
| Price to Sales Ratio | 2.51 |
| Price to Cash Ratio | 35.8 |
| Price to Book Ratio | 3.31 |
| Dividend Yield | - |
| Shares Outstanding | 350.76M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 13.16% |
| 52 Week High | 1.97 |
| 52 Week Low | 1.45 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Terrascend Corporation (QX) |
| Address |
3610 mavis road mississauga, ontario L5C 1W2 |
| Website | https://www.terrascend.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
